Eiger BioPharmaceuticals Garners $6,000,000 New Funding Round

  • Feed Type
  • Date
    11/23/2015
  • Company Name
    Eiger BioPharmaceuticals
  • Mailing Address
    350 Cambridge Ave. Palo Alto, CA 94306 USA
  • Company Description
    Eiger BioPharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis.
  • Website
    http://www.eigerbio.com
  • Transaction Type
    Debt
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy